Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus
This study aimed to indicate whether autologous bone marrow cell infusion (ABMI) via the right omental vein (ROV) could have a regulatory effect on decompensated liver cirrhosis (DLC) patients with type 2 diabetes mellitus (T2DM). For this purpose, 24 DLC patients with T2DM were divided into observa...
Guardado en:
Autores principales: | Baochi Liu, Mingrong Cheng, Lin Lang, Lei Li, Yanhui Si, Guangmian Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/058bde326aaf4c05a60d97ed690c01eb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sequential Changes in the Mesenteric Lymph Node Microbiome and Immune Response during Cirrhosis Induction in Rats
por: Alba Santiago, et al.
Publicado: (2019) -
Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study
por: Shanshan Sun, et al.
Publicado: (2021) -
Step by Step: Managing the Complications of Cirrhosis
por: Perez IC, et al.
Publicado: (2021) -
Management of Ascites in Patients with Cirrhosis: An Update
por: Giacomo Zaccherini, et al.
Publicado: (2021) -
Bone marrow research
Publicado: (2011)